A study of patients with porto-sinusoidal vascular disorder
Part of Digestive system clinical trials.
This study looks at people with a rare liver condition called porto-sinusoidal vascular disorder (PSVD), which affects blood flow in the liver. It aims to learn more about what causes it and how it affects patients over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with PSVD through a liver biopsy.
- The biopsy must show no signs of cirrhosis (advanced liver scarring).
- You must not have other liver diseases like Budd-Chiari syndrome or liver cancer.
- You must be at least 18 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests non-invasive methods to diagnose a liver condition called PSVD in people who have received platinum chemotherapy. It may help find liver problems early without a biopsy.
This study looks at people who have both liver blood vessel issues and high blood pressure in the lungs. It aims to learn more about this condition and how it affects people over time, which may help improve future care.
This study uses a special ultrasound with contrast to help tell apart two conditions that cause high blood pressure in the liver: porto-sinusoidal vascular disorder (a rare disease of the liver's small blood vessels) and cirrhosis (scarring of the liver). The test may help avoid the need for a liver biopsy.
This study looks for genetic causes of a rare combination of conditions: a liver blood vessel problem (congenital portosystemic shunt) and high blood pressure in the lungs (portopulmonary hypertension). It requires both parents and a sibling to also give blood samples so researchers can compare genes within the family.
This trial compares patients who have a rare liver condition (porto-sinusoidal vascular disease) with those who have cirrhosis, to see how a procedure called TIPS (a shunt placed in the liver to reduce blood pressure) works for complications like bleeding, fluid buildup, or blood clots.
This trial is for people with liver problems and high blood pressure in the veins of the liver (called portal hypertension). It will look at how the condition affects patients with and without cirrhosis (scarring of the liver).
Hear when a new Porto-Sinusoidal Vascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.